- > Frequently Asked Questions (FAQ) on Mouse Models for Ophthalmic Diseases
- > Revolutionizing Neovascular Ophthalmology Research: Cyagen's Phenotypically Stable Humanized VEGF Mice
- > Vision Stolen by Years - Age-related Macular Degeneration
- > Accelerating CAR-T Cell Therapy Research
- > Preclinical Pharmacological Model of CAR T-Cell Therapy
Most Popular
|
Newsletter
Breaking News
|
| Cyagen and Lumiere Therapeutics Forge Strategic Partnership to Advance Commercialization of the enCas12Ultra Base Editing System |
| Nov 18, 2024 |
| Recently, Cyagen (Suzhou) Biosciences Co., Ltd. ("Cyagen") signed a strategic cooperation agreement with Lumiere Therapeutics (Suzhou) Co., Ltd. ("Lumiere") to jointly advance the commercialization of Lumiere’s enCas12Ultra. Read More > |
|
Research Trends
|
| Inducible Cre & Fluorescent Reporter Mouse Model for Obesity Research: Agrp-IRES-CreERT2-P2A-tdTomato Mice |
| Nov 08, 2024 |
| Obesity and hunger are two closely related physiological states involving complex neural and hormonal regulatory mechanisms. Read More > |
|
Research Trends
|
| B6-Igl Knockout Mice: Research Model for B Cell Development & Antibody Diversity |
| Oct 31, 2024 |
| The novel B6-Igl Knockout (KO) mouse model exclusively expresses κ light chain immunoglobulins, offering researchers a powerful tool for exploring B cell development and antibody diversity. Read More > |
|
Research Trends
|
| USH2A Humanized Disease Model for Usher Syndrome Type II Research |
| Oct 25, 2024 |
| Usher Syndrome (USH) is a genetic disorder that causes both hearing and vision loss due to mutations in genes which play a critical role in inner ear and retinal function. Read More > |
|
Research Trends
|
| Familial Dysautonomia (FD) Humanized Disease Models: ELP1 & ELP1 IVS20+6T>C |
| Oct 18, 2024 |
| With the advancement of whole-genome sequencing, it has become increasingly recognized that intronic mutations play a significant role in various diseases, particularly rare diseases. Read More > |
|
Research Trends
|
| Hep G2 Cell Line: Liver Cancer Research Applications with Gene Editing & CDX Tumor Models |
| Oct 10, 2024 |
| Explore Hep G2 cell line applications in liver cancer research, gene editing using Smart-CRISPR™, and subcutaneous xenograft (CDX) tumor models. Discover best practices for cell culture, gene editing services, and tumor modeling. Read More > |
|
Research Trends
|
| HSD17B13 Humanized Mouse Model: A Breakthrough Tool for MASLD and RNAi Therapy Research |
| Sep 27, 2024 |
| Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex, multifactorial condition that has become a leading cause of liver-related morbidity and mortality. Read More > |
|
Research Trends
|
| How the B6-hTGFBI Humanized Mouse Model is Advancing Corneal Dystrophy Research |
| Sep 23, 2024 |
| Corneal dystrophy (CD) is a group of rare hereditary disorders caused by abnormal deposits of substances in the cornea. Read More > |
|
Research Trends
|
| Unveiling the Secrets of the DIO-B6-M Mouse Model for Obesity Research |
| Sep 13, 2024 |
| Obesity has become a global health issue. According to statistics, 2.5 billion adults were classified as overweight in 2022, with over 890 million suffering from obesity. Read More > |
|
Research Trends
|
| How to Culture & Edit NCI-H358 Cells: Best Practices for KRAS G12C Mutation Research |
| Sep 05, 2024 |
| Lung cancer researchers often utilize the NCI-H358 cell line for its KRAS G12C mutation to test inhibitors specifically targeting this mutation, as well as explore potential combination therapy strategies. Read More > |
